RE:RE:RE:SellTelesta could well be the first Phase 3 company to sell out below its cash value and at less than its current share price. Investors and shareholders would lose big time but they would be part of biotech lore forever. If it can be done this is the place where it would happen. I still think it would run into the low teens at least on a buyout rumor leak though.